GC
SSKN

Guggenheim Capital’s Strata Skin Sciences SSKN Stock Holding History

Guggenheim Capital’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-305
Closed -$9K – 2866
2017
Q1 		$9K Buy
305
+2
+0.7% +$57 ﹤0.01% 2820
2016
Q4 		$7K Hold
303
– – ﹤0.01% 2890
2016
Q3 		$8K Buy
+303
New +$9.64K ﹤0.01% 2870
2014
Q3 		– Sell
-53
Closed -$8K – 3103
2014
Q2 		$8K Sell
53
-5
-9% -$1.13K ﹤0.01% 3191
2014
Q1 		$18K Buy
58
+13
+29% +$4.57K ﹤0.01% 3238
2013
Q4 		$14K Buy
45
+3
+7% +$1.07K ﹤0.01% 3154
2013
Q3 		$15K Hold
42
– – ﹤0.01% 3032
2013
Q2 		$20K Buy
+42
New +$22.5K ﹤0.01% 2987

Other funds holding SSKN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Azzad Asset Management Falls Church, Virginia $1.13B AUM 38.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital's SSKN Position: Q2 2017 in Review

Guggenheim Capital sold out of Strata Skin Sciences (SSKN) in Q2 2017, closing a stake of 305 shares — an estimated $9K sold.

Guggenheim Capital first reported a position in SSKN in Q2 2013 and held it in 8 quarters. The position peaked at $20K in Q2 2013. 18 funds tracked by Wall St. Rank hold SSKN as of Q2 2017.

  • Guggenheim Capital reported no remaining Strata Skin Sciences position as of Q2 2017 after selling out during the quarter.
  • Guggenheim Capital sold 305 Strata Skin Sciences shares in Q2 2017, an estimated $9K.
  • Guggenheim Capital first reported a position in Strata Skin Sciences in Q2 2013 and held it in 8 quarters.
  • Guggenheim Capital's Strata Skin Sciences position peaked at $20K in Q2 2013.
  • 18 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q2 2017.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.